↓ Skip to main content

The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, September 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)

Mentioned by

blogs
1 blog
twitter
3 X users
facebook
4 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists
Published in
Allergy, Asthma & Clinical Immunology, September 2010
DOI 10.1186/1710-1492-6-26
Pubmed ID
Authors

Jason Behrmann

Abstract

Despite over a century of clinical use and a well-documented record of efficacy and safety, a growing minority in society questions the validity of vaccination and fear that this common public health intervention is the root-cause of severe health problems. This article questions whether growing public anti-vaccine sentiments might have the potential to spill-over into other therapies distinct from vaccination, namely allergen-immunotherapy. Allergen-immunotherapy shares certain medical vernacular with vaccination (e.g., allergy shots, allergy vaccines), and thus may become "guilty by association" due to these similarities. Indeed, this article demonstrates that anti-vaccine websites have begun unduly discrediting this allergy treatment regimen. Following an explanation of the anti-vaccine movement, the article aims to provide guidance on how clinicians can respond to patient fears towards allergen-immunotherapy in the clinical setting. This guide focuses on the provision of reliable information to patients in order to dispel misconceived associations between vaccination and allergen-immunotherapy, and the discussion of the risks and benefits of both therapies in order to assist patients in making autonomous decisions about their choice of allergy treatment.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 2%
Spain 1 2%
Unknown 46 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 29%
Student > Master 5 10%
Other 4 8%
Researcher 3 6%
Student > Postgraduate 3 6%
Other 9 19%
Unknown 10 21%
Readers by discipline Count As %
Medicine and Dentistry 16 33%
Agricultural and Biological Sciences 4 8%
Arts and Humanities 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Social Sciences 3 6%
Other 8 17%
Unknown 11 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2016.
All research outputs
#2,864,051
of 25,374,917 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#177
of 924 outputs
Outputs of similar age
#11,198
of 105,725 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#1
of 2 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 924 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them